Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Rakuten Medical, Inc.

Clinical trials sponsored by Rakuten Medical, Inc., explained in plain language.

Now part of Rakuten Group, Inc. 4755 TOKYO

A biotech developing photoimmunotherapy for cancer, backed by Rakuten.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1
Sort by
  • Light-Activated drug combo takes on recurrent head and neck cancer in major trial

    Disease control Recruiting now

    This phase 3 trial tests whether a new treatment called ASP-1929 photoimmunotherapy (a light-activated drug) combined with the immunotherapy pembrolizumab works better than standard care for people with recurrent head and neck cancer that hasn't spread to other parts of the body.…

    Phase: PHASE3 • Sponsor: Rakuten Medical, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 07:54 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space